Operating Lease, Right-of-Use Asset of Sigyn Therapeutics, Inc. from 30 Jun 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sigyn Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2021 to 31 Mar 2025.
  • Sigyn Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $97,181, a 37% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sigyn Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $97,181 -$57,202 -37% 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q4 2024 $112,079 -$55,657 -33% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $126,571 -$54,164 -30% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 $140,667 -$52,722 -27% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $154,383 -$51,328 -25% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $167,736 -$49,982 -23% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q3 2023 $180,735 -$48,683 -21% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $193,389 -$47,429 -20% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $205,711 -$46,220 -18% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $217,718 -$45,053 -17% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $229,418 -$46,908 -17% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $240,818 -$46,365 -16% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $251,931 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $262,771 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $276,326 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $287,183 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.